found numerically higher serum leptin levels in an SLE group that did not reach statistical significance. 6 Sample size, patient demographics, clinical heterogeneity, and therapeutic effects may account for these differences.
← all excerpts
High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
1
—
—